APSCVIR Membership

Please see attached letter regarding personal APSCVIR membership for

IRSA Members.

Personal APSCVIR membership


APSCVIR Gold medal Award

Irsa would like to congratulate Dr Robert Allen on presentation of the APSCVIR Gold medal award in Auckland.

As an early pioneer of IR, inventor, and genius in IR design, Rob has trained a wealth of IRs around the Asia Pacific region.

Rob is one of the founding figures of IR in Australia, and is to be commended on his great lifetime achievement!

The award was presented by IRSA President Dr Gerard Goh at the Gala dinner.




EBIR Holders 2018

EBIR 2018

IRSA would like to congratulate all the Australian and New Zealand candidates of the 2018 EBIR held in Auckland. All candidates were successful in passing the EBIR, and there are now 76 EBIR holders in Australia and New Zealand EBIR Holders Australlia and New Zealand 2018


IRSA Registrar Conference 2018

IRSA Registrar Conference 2018, Alfred Hospital Melbourne

A reminder to members that the IRSA Registrar weekend will take place at the Alfred Hospital over the weekend of 23rd/24th June 2018.

As in previous years the convenors aim to educate the next generation of Radiology trainees in the basic concepts, techniques and equipment in the IR world.

Registrars will be nominated by Heads of Dept/ Directors of Training, so please register your interest to attend.

Calling all Interventional Radiologists interested in Interventional Oncology!

The Interventional Oncology Special Interest Group will meet in Hobart March 20-21, 2018, during the Annual TROG meeting. All IRs interested in Interventional Oncology are encouraged to attend and participate in the planning of future IO research projects in Australia and New Zealand.

This will be a "research meeting” focussing on current, future and aspirational research projects. The IO committee has two projects that have been accepted for inclusion in this meeting:

    • Percutaneous ablation of renal masses
    • Percutaneous ablation of lung cancer 

If successful, these projects will receive the full resources of TROG and be the first research projects across a formal network of IR Departments across Australia and New Zealand. This would be a great step forward for Trans-Tasman IO, and presents an opportunity for all IRs to get involved. 

Future research strategy workshops will also be held, including for research projects in other systems such as hepatobiliary oncology, and how the IO Group can best work with RANZCR and IRSA to support IO. Now is the time to get involved and help shape the future of interventional oncology.

A special registration fee for IRs is available for $340, which will cover all IO sessions (Tuesday and Wednesday). 

Medtronic and Terumo have generously sponsored the IR content for this meeting.

Please visit http://www.cmnzl.co.nz/trog-2018-asm/ to register, or contact trog@trog.com.au.

We hope to see you there!

Nick Brown & Liz Kenny

Co-chairs, Interventional Oncology

TROG Special Interest Group